WU Q et al. ment in the study. Patients (aged 18-60 years) undergoing MVR surgery were eligible for inclusion. Exclusion criteria included other heart abnormalities; New York Heart Association class IV; history of respiratory infection, asthma or cardiac surgery; hepatic, renal, or pulmonary disease; peripheral vascular disease affecting limbs; and patients taking the antidiabetic sulfonylurea, glibenclamide, because this agent has been shown in experimental studies to abrogate the cardioprotection elicited by ischemic preconditioning. 12 Patients were randomly assigned to 3 groups before MVR surgery: control group (n=25), LIPC group I (n=25) and LIPC group II (n=25).
LIPC Protocol
LIPC consisted of 3×5-min cycles of right upper arm ischemia and 5-min reperfusion in LIPC I, and 3×5-min cycles of the right upper arm ischemia and 5-min reperfusion combined with 2×10-min cycles of right upper leg ischemia and 10-min reperfusion in LIPC II. Limb ischemia was induced by an automated cuff-inflator either placed on the right upper arm and inflated to 200 mmHg or placed on the right upper leg and inflated to 450 mmHg. Control patients had a deflated cuff placed on the right upper arm for 30 min. LIPC was performed after anesthesia induction and before surgery started.
Anesthetic Technique and Cardiopulmonary Bypass (CPB)
Patients were premedicated with diazepam (10 mg IM) and scopolamine (0.3 mg IM) 30 min before surgery. On arrival in the anesthetic room, a peripheral venous cannula was inserted and lactated Ringer's solution was infused. An arterial cannula was inserted before anesthesia and arterial pressure was continuously monitored. Anesthesia was induced with midazolam (0.05-0.1 mg/kg), fentanyl (10-20 μg/kg), and vecuronium (0.1 mg/kg). The trachea was intubated and mechanical ventilation with 100% oxygen was begun. Blood gas analysis was performed to adjust the tidal volume to maintain normal arterial carbon dioxide. Anesthesia was maintained with intravenous administration of midazolam (0.1 mg · kg -1 · h -1 ), sufentanyl (2.0-3.0 μg · kg -1 · h -1 ) and vecuronium (0.1 mg · kg -1 · h -1 ). Central venous catheter was inserted in the right internal jugular vein after intubation.
The CPB circuit included a membrane oxygenator and a roller pump system. 13 The pump priming solution consisted of sufficient crystalloid and 20% albumin to keep the hematocrit value between 25% and 30%. Anticoagulation was accomplished by intravenous administration of heparin sulfate, which was neutralized with protamine sulfate at the end of CPB. Cannulation was accomplished using the ascending aorta for inflow and the inferior and superior venae cavae for the outflow. Cardiac arrest was accomplished by aortic cross clamping coupled with infusion of high-potassium blood cardioplegic solution (4-7°C, [K + ] 20 mmol/L) through the aortic root. Cardioplegic solution was given intermittently and the average interval was 30 min. Retrograde cardioplegia was not used in any case. Mild systemic hypothermia (temperature >28°C and <32°C) was maintained during aortic cross-clamping. 14 When suturing the valve was almost completed, patients were slowly rewarmed. The atrial septum and the heart were closed, deaired, and the aortic clamp was removed. Warm blood cardioplegic solution was not given before removing the aortic clamp. Hemodynamics had to be stable before weaning from bypass. Blood gas management during CPB was directed towards maintenance of homeostasis.
Clinical Observation Indices CPB time, cross-clamp time, cardiac index (CI), inotropic requirement, intensive care stay, and postoperative stay in hospital were recorded. The latter 3 indices were recorded in the intensive care unit by nurses who were not involved in the study and were unaware of the grouping. Postoperative arterial pressure-based cardiac output was measured by the FloTrac/Vigileo system (Edwards Lifesciences, Irvine, CA, 
Blood Analysis
Blood samples for measurement of cardiac troponin I (cTnI) were collected from the arterial cannula before surgery and immediately, 4, 8, 12, 24, 48 , and 72 h after surgery. Blood gas analysis was done and hematocrit was recorded at each time point. Plasma was obtained by centrifugation at 4,000 rpm for 15 min and then stored at -20°C. Plasma cTnI concentrations were analyzed by Abbott automatic biochemistry analyzer with matching kits within 5 days of collecting the samples. The correction value of cTnI was obtained according to the formula: correction value of cTnI = (preoperative hematocrit value × cTnI value)/sampling hematocrit value. Figure.
Changes in the plasma levels of cardiac troponin I (cTnI) in the 3 groups. Data are mean ± SD. *P<0.05 vs. the control group. T1, before surgery; T2, end of surgery; T3, 4 h after surgery; T4, 8 h after surgery; T5, 12 h after surgery; T6, 24 h after surgery; T7, 48 h after surgery; T8, 72 h after surgery. LIPC, limb ischemic preconditioning. WU Q et al.
Statistical Analysis
Data are expressed as mean ± SD and were analyzed by SPSS software (SPSS Inc, Chicago, IL, USA Tables 2, 3 ).
Measurement of cTnI
Plasma levels of cTnI in the 3 groups significantly stepped up during CPB and peaked at 4 h after surgery. Levels of cTnI between the control and LIPC I groups were not statistically different, but levels of cTnI in LIPC I were relatively lower than the control group at each time point after surgery. Levels of cTnI in LIPC II were significantly lower than in the control group at each time point after surgery ( Figure) .
Discussion
In this study, increasing the intensity of LIPC, mediated by 3×5-min cycles of right upper arm ischemia and 5-min reperfusion combined with 2×10-min cycles of right upper leg ischemia and 10-min reperfusion, reduced the cTnI level in the perioperative period in patients undergoing MVR surgery and decreased the inotropic requirement after surgery. At present, cTnI is considered to be one of the most specific and sensitive markers for the diagnosis and monitoring of acute myocardial infarction, unstable angina and perioperative myocardial injury. A series of studies confirmed the value of cTnI after cardiac surgery associated with shortand long-term complications. Vermes et al showed that cTnI could be a marker of myocardial ischemia after open heart surgery. 16 Lasocki et al have shown that the cTnI concentration measured 20 h after the end of surgery is an independent predictor of in-hospital death after cardiac surgery, and elevated concentrations of cTnI were associated with both a cardiac cause of death and major postoperative complications. 17 In our study, the plasma levels of cTnI in the control group significantly stepped up during CPB and reached their peak at 4 h after surgery, indicating obvious myocardial injury in patients undergoing MVR surgery. Levels of cTnI in LIPC II were significantly lower than in the control group at each time point after surgery, which suggests that increasing the intensity of LIPC can protect the myocardium from IRI in patients undergoing MVR surgery.
Our study also confirms the requirement for the preconditioning stimulus to cross a threshold. LIPC consisting of 3× 5-min cycles of right upper arm ischemia and 5-min reperfusion in LIPC I did not significantly reduce cTnI compared with the control group, whereas when it consisted of 3× 5-min cycles of right upper arm ischemia and 5-min reperfusion combined with 2×10-min cycles of right upper leg ischemia and 10-min reperfusion the cTnI level was reduced. Loukogeorgakis et al found that RIPC (3×5-min cycles of arm ischemia and 5-min reperfusion or 3×5-min cycles of leg ischemia and 5-min reperfusion) immediately before IR preserved endothelial function, and that RIPC administered as 2 cycles was effective only when applied to the leg. 18 Hausenloy et al showed that adult patients undergoing elective coronary artery bypass graft surgery at a single tertiary centre could benefit from RIPC using only 3×5-min cycles of right upper limb IR. 10 Why are our study results different from these previous studies? Compared with other studies, ours concentrated on patients undergoing MVR surgery, which has more chance of myocardial injury than do patients undergoing coronary artery bypass graft surgery, so more potent pretreatment was needed to obtain myocardial protection. Cheung et al 9 demonstrated the myocardial protective effects of RIPC using a simple noninvasive technique of 4× 5-min cycles of lower limb ischemia and 5-min reperfusion. Postoperative levels of cTnI were greater in the control patients than in the RIPC group, indicating greater myocardial injury in the control patients. The postoperative inotropic requirement was greater in the control patients than in the RIPC patients at both 3 and 6 h (7.9±4.7 μg · kg -1 · min -1 vs. 10.9±3.2 μg · kg -1 · min -1 ; 7.3±4.9 μg · kg -1 · min -1 vs. 10.8± 3.9 μg · kg -1 · min -1 ).
In this study, CI, inotropic requirement, intensive care stay and postoperative hospital stay were used to evaluate postoperative recovery. 19 Many factors influence with postoperative recovery, such as CPB time, cross-clamp time, surgical techniques, CPB mode etc. CI, the cumulative postoperative dosage of dobutamine, intensive care stay and postoperative hospital stay were not statistically different. Although the cumulative postoperative dosage of dobutamine was not different, there was a significantly lower inotropic requirement in LIPC II compared with the control group at 4 and 8 h after surgery.
The actual mechanism by which RIPC protects the myocardium is unclear. Information transfer in RIPC may be mediated by humoral mediators or through a neurogenic path or a combination of both, and involves adenosine, 20,21 opioids, 22 bradykinins, 23 protein kinase C, 24 and ATP-sensitive potassium channels. 18, 25 Whatever the pathway, the basic mechanism of a preconditioning stimulus is the transfer and storage of information to prime signal pathways, which raises the threshold of cells to subsequent injury. As LIPC is a relatively more feasible and operable form of RIPC, exploring its protective effect has a strong clinical significance.
In short, our research suggests that myocardial injury in patients with MVR surgery is inevitable. LIPC can reduce the postoperative cTnI value and inotropic requirement to a certain extent, but it also should be noted that LIPC did not significantly reduce intensive care stay and postoperative hospital stay, and thus the protective effects of LIPC remain to be further researched. However, this study confirms the relationship between the protective effect and the preconditioning method, and provides a basis for developing a simpler and more effective method of preconditioning.
